Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current in a perfused heart model

Pharmacotherapy

Volumn 28, Issue 11 PART 1, 2008, Pages 1315-1324

  Overholser, Brian R ^a,b   Zheng, Xiaomei ^a,b   Tisdale, James E ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Adrenergic; Catecholamine; Epinephrine; IKr; Norepinephrine; Rapid component of the delayed rectifier potassium current; Repolarization

Indexed keywords

ADRENALIN; BUFFER; DELAYED RECTIFIER POTASSIUM CHANNEL; NORADRENALIN; SPARFLOXACIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; BODY TEMPERATURE; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EXCISION; GUINEA PIG; HEART BEAT; HEART PERFUSION; HEART REPOLARIZATION; MALE; NONHUMAN;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CATECHOLAMINES; DELAYED RECTIFIER POTASSIUM CHANNELS; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; GUINEA PIGS; MALE; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNEL BLOCKERS; VENTRICULAR DYSFUNCTION;

EID: 55549128921     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.11.1315     Document Type: Article

References (30)

1. Steinberg SF, Robinson RB, Rosen MR. Molecular and cellular bases of β-adrenergic and α-adrenergic modulation of cardiac rhythm. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside, 4th ed. Philadelphia: W.B. Saunders Company, 2004:291-8.
2. Chen LS, Zhou S, Fishbein MC, Chen PS. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007;18:123-7.
3. Noda T, Takaki H, Kurita T, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 2002;23:975-83.
4. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
5. Ks to canine ventricular repolarization: key role for β-adrenergic receptor stimulation. Circulation 2003;107:2753-60.
6. Veldkamp MW, Verkerk AO, van Ginneken AC, et al. Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts. Eur Heart J 2001;22:955-63.
7. Anderson ME, Mazur A, Yang T, Roden DM. Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. J Pharmacol Exp Ther 2001;296:806-10.
8. + channel HERG. Mol Pharmacol 2001;59:122-6.
9. Rubart M, Pressler ML, Pride HP, Zipes DP. Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation 1993;88(4 pt 1):1832-44.
10. Franz MR. Method and theory of monophasic action potential recording. Prog Cardiovasc Dis 1991;33:347-68.
11. Hondeghem LM. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability). Novartis Found Symp 2005;266:235-44.
12. Guo D, Zhao X, Wu Y, Liu T, Kowey PR, Yan GX. L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation. J Cardiovasc Electrophysiol 2007;18:196-203.
13. Milberg P, Hilker E, Ramtin S, et al. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. J Cardiovasc Electrophysiol 2007;18:647-54.
14. Bode F, Wiegand U, Raasch W, Richardt G, Potratz J. Differential effects of defibrillation on systemic and cardiac sympathetic activity. Heart 1998;79:560-7.
15. Roden DM, Yang T. Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve. Circulation 2005;112:1376-8.
16. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for β-adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002;295:496-9.
17. Fedida D, Shimoni Y, Giles WR. α-Adrenergic modulation of the transient outward current in rabbit atrial myocytes. J Physiol 1990;423:257-77.
18. + current in rabbit ventricular myocytes. J Physiol 1991;441:673-84.
19. + currents in isolated adult rat ventricular myocytes. J Gen Physiol 1991;97:973-1011.
20. 1- adrenoceptors modulates the inwardly rectifying potassium currents of mammalian atrial myocytes. Pflugers Arch 1992;421:431-9.
21. + current in human atrial myocytes. Circ Res 1996;78:903-15.
22. Chen PS. The Douglas P Zipes lecture: neural mechanisms of atrial fibrillation. Heart Rhythm 2006;3:1373-7.
23. Wilde AA, Jongbloed RJ, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 1999;33:327-32.
24. Viitasalo M, Paavonen KJ, Swan H, Kontula K, Toivonen L. Effects of epinephrine on right ventricular monophasic action potentials in the LQT1 versus LQT2 form of long QT syndrome: preferential enhancement of "triangulation" in LQT1. Pacing Clin Electrophysiol 2005;28:219-27.
25. Michael G, Dempster J, Kane KA, Coker SJ. Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation. Br J Pharmacol 2007;152:1215-27.
26. + currents in the heart. Am J Physiol Heart Circ Physiol 2003;285:H1641-9.
27. 5) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc Res 1998;40:322-31.
28. Ks in epicardium and endocardium contributes to development of transmural dispersion of repolarization but protects against development of early afterdepolarizations. J Cardiovasc Electrophysiol 2002;13:172-7.
29. Shimizu W, McMahon B, Antzelevitch C. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol 1999;10:154-64.
30. D'Alonzo AJ, Zhu JL, Darbenzio RB. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe. Eur J Pharmacol 1999;369:57-64.